Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Apoptosis of t(14;18)-positive lymphoma cells by a Bcl-2 interacting small molecule.

Abbott DR, Abbott RT, Jenson SD, Fillmore GC, Elenitoba-Johnson KS, Lim MS.

J Hematop. 2009 Jul;2(2):113-9. doi: 10.1007/s12308-009-0028-x. Epub 2009 Feb 28.

2.

P38 mitogen activated protein kinase expression and regulation by interleukin-4 in human B cell non-Hodgkin lymphomas.

Ding H, Gabali AM, Jenson SD, Lim MS, Elenitoba-Johnson KS.

J Hematop. 2009 Oct 21;2(4):195-204. doi: 10.1007/s12308-009-0049-5.

3.

Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.

Bohling SD, Jenson SD, Crockett DK, Schumacher JA, Elenitoba-Johnson KS, Lim MS.

Leuk Res. 2008 Mar;32(3):383-93. Epub 2007 Aug 27.

PMID:
17720243
4.

Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins.

Elenitoba-Johnson KS, Crockett DK, Schumacher JA, Jenson SD, Coffin CM, Rockwood AL, Lim MS.

Proc Natl Acad Sci U S A. 2006 May 9;103(19):7402-7. Epub 2006 May 1.

5.

Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas.

Gouw LG, Reading NS, Jenson SD, Lim MS, Elenitoba-Johnson KS.

Br J Haematol. 2005 May;129(4):531-3.

PMID:
15877735
6.

Quantitative proteomic and transcriptional analysis of the response to the p38 mitogen-activated protein kinase inhibitor SB203580 in transformed follicular lymphoma cells.

Lin Z, Crockett DK, Jenson SD, Lim MS, Elenitoba-Johnson KS.

Mol Cell Proteomics. 2004 Aug;3(8):820-33. Epub 2004 May 28.

7.
8.
9.

Validation of cDNA microarray gene expression data obtained from linearly amplified RNA.

Jenson SD, Robetorye RS, Bohling SD, Schumacher JA, Morgan JW, Lim MS, Elenitoba-Johnson KS.

Mol Pathol. 2003 Dec;56(6):307-12.

10.

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy.

Elenitoba-Johnson KS, Jenson SD, Abbott RT, Palais RA, Bohling SD, Lin Z, Tripp S, Shami PJ, Wang LY, Coupland RW, Buckstein R, Perez-Ordonez B, Perkins SL, Dube ID, Lim MS.

Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7259-64. Epub 2003 May 19.

11.

5'-(RACE) identification of rare ALK fusion partner in anaplastic large cell lymphoma.

Reading NS, Jenson SD, Smith JK, Lim MS, Elenitoba-Johnson KS.

J Mol Diagn. 2003 May;5(2):136-40. No abstract available.

12.

Gene expression profiling of cell lines derived from T-cell malignancies.

Fillmore GC, Lin Z, Bohling SD, Robetorye RS, Kim CH, Jenson SD, Elenitoba-Johnson KS, Lim MS.

FEBS Lett. 2002 Jul 3;522(1-3):183-8.

13.

Fluorescence PCR quantification of cyclin D1 expression.

Elenitoba-Johnson KS, Bohling SD, Jenson SD, Lin Z, Monnin KA, Lim MS.

J Mol Diagn. 2002 May;4(2):90-6.

Supplemental Content

Loading ...
Support Center